News
13hon MSN
The battle of the weight-loss drugs
Some of the losses are down to pharma's broader problems: notably, President Trump's tariff and price-cut threats. But there ...
1don MSNOpinion
Voices: Yes, Mounjaro is set to treble in price – but don’t abandon weight-loss jabs until you read this
COMMENT: The monthly cost of a private prescription exceeding £300 from next month is worrying news for the half a million ...
Williams left the world of tennis behind back in 2022, when she played the final match of her career in the US Open, but she ...
The Food and Drug Administration approved the weight loss drug Wegovy to treat an increasingly prevalent liver disease on ...
Tennis champion Serena Williams said Thursday that she is taking weight loss medication after struggling to see results from ...
The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.
Patients' vision loss, which is rare according to a new study, is also the subject of multiple lawsuits, including two filed ...
A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits ...
Key Takeaways Novo Nordisk's blockbuster weight-loss drug, Wegovy, received Food and Drug Administration approval to treat a ...
CheqUp said it had experienced a spike in interest from consumers wanting to switch or begin taking the medication ...
Sales of the weight loss injection Wegovy have skyrocketed in the UK after the manufacturer of rival drug Mounjaro announced ...
BRITAIN has gone fat jab crazy — with sales of Wegovy soaring by more than 2,000 per cent in the past month. Dieters are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results